Literature DB >> 27098907

Family history of rheumatoid arthritis: an old concept with new developments.

Thomas Frisell1, Saedis Saevarsdottir2,3, Johan Askling1,3.   

Abstract

Family history of rheumatoid arthritis (RA) is a proxy for an individual's genetic and, in part, environmental risk of developing RA, and is a well-recognized predictor of disease onset. Although family history of RA is an old concept, the degree of familial aggregation of RA, whether it differs by age, sex, or serology, and what value it has for clinical decisions once a diagnosis of RA has been made remain unclear. New data have been emerging in parallel to substantial progress made in genetic association studies. In this Review, we describe the various ways that familial aggregation has been measured, and how the findings from these studies, whether they are based on twins, cohorts of first-degree relatives, or genetic data, correspond to each other and aid understanding of the aetiology of RA. In addition, we review the potential usefulness of family history of RA from a clinical point of view, demonstrating that, in the era of big data and genomics, family history still has a role in directing clinical decision-making and research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27098907     DOI: 10.1038/nrrheum.2016.52

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  93 in total

1.  [Heredopathology of reactive mesenchymal disease (so-called collagen disease). I. Research on the hereditary factors in acute primary rheumatism].

Authors:  G G NERI SERNERI; V BARTOLI
Journal:  Acta Genet Med Gemellol (Roma)       Date:  1956-05

2.  Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population-based study.

Authors:  Rachel Knevel; Gerður Gröndal; Tom W J Huizinga; A Willemien Visser; Helgi Jónsson; Arnór Víkingsson; Arni Jón Geirsson; Kristján Steinsson; Annette H M van der Helm-van Mil
Journal:  Ann Rheum Dis       Date:  2012-01-04       Impact factor: 19.103

3.  Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history.

Authors:  Jeffrey A Sparks; Chia-Yen Chen; Xia Jiang; Johan Askling; Linda T Hiraki; Susan Malspeis; Lars Klareskog; Lars Alfredsson; Karen H Costenbader; Elizabeth W Karlson
Journal:  Ann Rheum Dis       Date:  2014-03-31       Impact factor: 19.103

4.  Marginal genetic effects estimation in family and twin studies using random-effects models.

Authors:  Roula Tsonaka; Diane van der Woude; Jeanine Houwing-Duistermaat
Journal:  Biometrics       Date:  2015-07-06       Impact factor: 2.571

5.  Can familial aggregation of disease be explained by familial aggregation of environmental risk factors?

Authors:  M J Khoury; T H Beaty; K Y Liang
Journal:  Am J Epidemiol       Date:  1988-03       Impact factor: 4.897

6.  HLA-linked rheumatoid arthritis.

Authors:  S J Hasstedt; D O Clegg; L Ingles; R H Ward
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

7.  Rheumatoid arthritis in identical twins: a clinical and immunogenetic study of eight concordant pairs derived from a nationwide twin panel.

Authors:  P Järvinen; M Koskenvuo; S Koskimies; K Kotaniemi; K Aho
Journal:  Scand J Rheumatol       Date:  1991       Impact factor: 3.641

8.  Population genomics: laying the groundwork for genetic disease modeling and targeting.

Authors:  J Gulcher; K Stefansson
Journal:  Clin Chem Lab Med       Date:  1998-08       Impact factor: 3.694

9.  High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.

Authors:  Steve Eyre; John Bowes; Dorothée Diogo; Annette Lee; Anne Barton; Paul Martin; Alexandra Zhernakova; Eli Stahl; Sebastien Viatte; Kate McAllister; Christopher I Amos; Leonid Padyukov; Rene E M Toes; Tom W J Huizinga; Cisca Wijmenga; Gosia Trynka; Lude Franke; Harm-Jan Westra; Lars Alfredsson; Xinli Hu; Cynthia Sandor; Paul I W de Bakker; Sonia Davila; Chiea Chuen Khor; Khai Koon Heng; Robert Andrews; Sarah Edkins; Sarah E Hunt; Cordelia Langford; Deborah Symmons; Pat Concannon; Suna Onengut-Gumuscu; Stephen S Rich; Panos Deloukas; Miguel A Gonzalez-Gay; Luis Rodriguez-Rodriguez; Lisbeth Ärlsetig; Javier Martin; Solbritt Rantapää-Dahlqvist; Robert M Plenge; Soumya Raychaudhuri; Lars Klareskog; Peter K Gregersen; Jane Worthington
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

10.  Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study.

Authors:  Daniela Di Giuseppe; Lars Alfredsson; Matteo Bottai; Johan Askling; Alicja Wolk
Journal:  BMJ       Date:  2012-07-10
View more
  31 in total

1.  Impact of Cyclic Citrullinated Peptide Antibody Level on Progression to Rheumatoid Arthritis in Clinically Tested Cyclic Citrullinated Peptide Antibody-Positive Patients Without Rheumatoid Arthritis.

Authors:  Julia A Ford; Xinyi Liu; Allison A Marshall; Alessandra Zaccardelli; Maria G Prado; Charlene Wiyarand; Bing Lu; Elizabeth W Karlson; Peter H Schur; Kevin D Deane; Jeffrey A Sparks
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-12       Impact factor: 4.794

Review 2.  Environmental factors and hormones in the development of rheumatoid arthritis.

Authors:  Deshiré Alpízar-Rodríguez; Axel Finckh
Journal:  Semin Immunopathol       Date:  2017-04-27       Impact factor: 9.623

Review 3.  Individuals at risk of seropositive rheumatoid arthritis: the evolving story.

Authors:  S Rantapää Dahlqvist; F Andrade
Journal:  J Intern Med       Date:  2019-10-21       Impact factor: 8.989

4.  [Family history of rheumatic diseases in patients with rheumatoid arthritis: a large scale cross-sectional study].

Authors:  X Y Zhang; J Y Jin; J He; Y Z Gan; J L Chen; X Z Zhao; J J Liu; X J You; X Li; J P Guo; X F Li; J Li; R Li; Z G Li
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-06-18

Review 5.  Genetic and environmental risk factors for rheumatoid arthritis.

Authors:  Kevin D Deane; M Kristen Demoruelle; Lindsay B Kelmenson; Kristine A Kuhn; Jill M Norris; V Michael Holers
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-09-18       Impact factor: 4.098

Review 6.  Immune checkpoint inhibitor-induced inflammatory arthritis as a model of autoimmune arthritis.

Authors:  Laura C Cappelli; Mekha A Thomas; Clifton O Bingham; Ami A Shah; Erika Darrah
Journal:  Immunol Rev       Date:  2020-01-13       Impact factor: 12.988

Review 7.  Modulation of autoimmune arthritis by environmental 'hygiene' and commensal microbiota.

Authors:  David Langan; Eugene Y Kim; Kamal D Moudgil
Journal:  Cell Immunol       Date:  2018-12-10       Impact factor: 4.868

8.  The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study.

Authors:  Koichi Murata; Motomu Hashimoto; Wataru Yamamoto; Yonsu Son; Hideki Amuro; Koji Nagai; Tohru Takeuchi; Masaki Katayama; Yuichi Maeda; Kosuke Ebina; Ryota Hara; Sadao Jinno; Akira Onishi; Kosaku Murakami; Masao Tanaka; Hiromu Ito; Tsuneyo Mimori; Shuichi Matsuda
Journal:  Rheumatol Int       Date:  2019-10-16       Impact factor: 2.631

Review 9.  Sexual Dimorphism in the Expression of Pain Phenotype in Preclinical Models of Rheumatoid Arthritis.

Authors:  Lauriane Delay; Gilson Gonçalves Dos Santos; Elayne Vieira Dias; Tony L Yaksh; Maripat Corr
Journal:  Rheum Dis Clin North Am       Date:  2021-02-26       Impact factor: 2.670

Review 10.  Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review.

Authors:  Marta Bryk; Katarzyna Starowicz
Journal:  Pharmacol Rep       Date:  2021-05-28       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.